{"id":"https://openalex.org/W2889864321","doi":"https://doi.org/10.1016/j.vascn.2018.01.412","title":"JTp and Tpe as Biomarkers of proarrhythmic risk in nonclinical models: Historical data evaluation by the HESI consortium","display_name":"JTp and Tpe as Biomarkers of proarrhythmic risk in nonclinical models: Historical data evaluation by the HESI consortium","publication_year":2018,"publication_date":"2018-09-01","ids":{"openalex":"https://openalex.org/W2889864321","doi":"https://doi.org/10.1016/j.vascn.2018.01.412","mag":"2889864321"},"language":"en","primary_location":{"id":"doi:10.1016/j.vascn.2018.01.412","doi":"https://doi.org/10.1016/j.vascn.2018.01.412","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.vascn.2018.01.412","pdf_url":null,"source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003248273","display_name":"Nicolas Gendron-Parra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Nicolas Gendron-Parra","raw_affiliation_strings":["University of Montreal, St-Hyacinthe, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Montreal, St-Hyacinthe, Canada","institution_ids":["https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087882959","display_name":"Matthew M. Abernathy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew M. Abernathy","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042048473","display_name":"Emmanuel Boulay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Emmanuel Boulay","raw_affiliation_strings":["University of Montreal, St-Hyacinthe, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Montreal, St-Hyacinthe, Canada","institution_ids":["https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021524110","display_name":"Ray W. Chui","orcid":"https://orcid.org/0000-0003-1162-8680","observed_orcids":["https://orcid.org/0000-0003-1162-8680"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ray Chui","raw_affiliation_strings":["Amgen, Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050732194","display_name":"Gregory S. Friedrichs","orcid":"https://orcid.org/0000-0002-8689-1830","observed_orcids":["https://orcid.org/0000-0002-8689-1830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory S. Friedrichs","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064835358","display_name":"Andrea Greiter\u2010Wilke","orcid":"https://orcid.org/0000-0002-6460-5135","observed_orcids":["https://orcid.org/0000-0002-6460-5135"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Andrea Greiter-Wilke","raw_affiliation_strings":["Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110445510","display_name":"Jean\u2010Michel Guillon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-michel Guillon","raw_affiliation_strings":["Sanofi, Vitry sur seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Vitry sur seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113829375","display_name":"Derek J. Leishman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Derek J. Leishman","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028619104","display_name":"Jill Nichols","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill Nichols","raw_affiliation_strings":["Covance, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance, Madison, WI, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072477887","display_name":"Jennifer Beck Pierson","orcid":"https://orcid.org/0000-0002-9551-0681","observed_orcids":["https://orcid.org/0000-0002-9551-0681"]},"institutions":[{"id":"https://openalex.org/I4210147691","display_name":"Health and Environmental Sciences Institute","ror":"https://ror.org/04bqs3e84","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210147691"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Pierson","raw_affiliation_strings":["HESI, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HESI, Washington, DC, USA","institution_ids":["https://openalex.org/I4210147691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025015337","display_name":"Matthew R Skinner","orcid":"https://orcid.org/0000-0002-9677-3352","observed_orcids":["https://orcid.org/0000-0002-9677-3352"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Skinner","raw_affiliation_strings":["Vivonics Preclinical Ltd, The Biohub at Alderley Park, Alderley Edge, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vivonics Preclinical Ltd, The Biohub at Alderley Park, Alderley Edge, Cheshire, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081274926","display_name":"Michael K. Pugsley","orcid":"https://orcid.org/0000-0002-4626-9975","observed_orcids":["https://orcid.org/0000-0002-4626-9975"]},"institutions":[{"id":"https://openalex.org/I4210124185","display_name":"Purdue Pharma (United States)","ror":"https://ror.org/030vvs717","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael K. Pugsley","raw_affiliation_strings":["Purdue Pharma L.P., Stamford, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Purdue Pharma L.P., Stamford, CT, USA","institution_ids":["https://openalex.org/I4210124185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052012032","display_name":"Jean\u2010Pierre Valentin","orcid":"https://orcid.org/0000-0002-3599-9155","observed_orcids":["https://orcid.org/0000-0002-3599-9155"]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jean-Pierre Valentin","raw_affiliation_strings":["UCB Biopharma SPRL, Braine-l'Alleud, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Biopharma SPRL, Braine-l'Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001580477","display_name":"Hugo M. Vargas","orcid":"https://orcid.org/0000-0001-9447-3164","observed_orcids":["https://orcid.org/0000-0001-9447-3164"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hugo M. Vargas","raw_affiliation_strings":["Amgen, Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056990117","display_name":"Simon Authier","orcid":"https://orcid.org/0000-0001-8134-4558","observed_orcids":["https://orcid.org/0000-0001-8134-4558"]},"institutions":[{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Simon Authier","raw_affiliation_strings":["CiToxLAB, Laval, Canada","University of Montreal, St-Hyacinthe, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CiToxLAB, Laval, Canada","institution_ids":[]},{"raw_affiliation_string":"University of Montreal, St-Hyacinthe, Canada","institution_ids":["https://openalex.org/I70931966"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5056990117"],"corresponding_institution_ids":["https://openalex.org/I70931966"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17524484,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"93","issue":null,"first_page":"121","last_page":"121"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10745","display_name":"Heart Rate Variability and Autonomic Control","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tpe","display_name":"TPE","score":0.9190000295639038},{"id":"https://openalex.org/keywords/proarrhythmic-risk","display_name":"proarrhythmic risk","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cardiac-biomarkers","display_name":"cardiac biomarkers","score":0.5929999947547913},{"id":"https://openalex.org/keywords/drug-induced-arrhythmia","display_name":"drug-induced arrhythmia","score":0.5920000076293945},{"id":"https://openalex.org/keywords/qt-interval","display_name":"QT interval","score":0.42800000309944153},{"id":"https://openalex.org/keywords/electrocardiography","display_name":"electrocardiogram","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49446964263916016},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4065089821815491}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.vascn.2018.01.412","doi":"https://doi.org/10.1016/j.vascn.2018.01.412","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.vascn.2018.01.412","pdf_url":null,"source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2981154370","https://openalex.org/W620672834","https://openalex.org/W2905707403","https://openalex.org/W7211892751","https://openalex.org/W2890663120","https://openalex.org/W2155025525","https://openalex.org/W3095067041","https://openalex.org/W2929411883","https://openalex.org/W2029635286","https://openalex.org/W2980803482"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2018-09-27T00:00:00"}